ERS Satellites 2020
20 – 21 February, 2020 ERS satellites is an award-winning modern approach to delivering education to a global audience. Connecting four live audiences using cutting edge live streaming technology to…
Targeted Therapies in Severe Asthma: When to Use Them (and Why)
Format Clinical Review Time to Complete 45 minutes START ACTIVITY MAXIMUM CREDITS 0.75 / AMA PRA Category 1 CreditTM ACCREDITED PROVIDER This CME-certified enduring activity is jointly provided by Rutgers Biomedical…
A randomized, double-blind, placebo-controlled, parallel-group study of once-daily inhaled fluticasone furoate on the hypothalamic–pituitary–adrenocortical axis of children with asthma
Research – Open Access Philippe Bareille, Susan Tomkins, Varsha Imber, Mohammed Tayob, Karen Dunn, Rashmi Mehta & Sanjeev Khindri Allergy, Asthma & Clinical Immunology volume 16, 11 (2020) Abstract Background To evaluate the effects of fluticasone furoate on the hypothalamic–pituitary–adrenocortical…
Inhaled Itraconazole Fast-Tracked for Allergic Bronchopulmonary Aspergillosis in Asthma
Brian Park, PharmD The Food and Drug Administration has granted Fast Track designation to PUR1900 (Pulmazole; Pulmatrix) for the treatment of allergic bronchopulmonary aspergillosis (ABPA) in patients with asthma. ABPA…
CME / ABIM MOC: Severe Asthma: Current Evidence for Phenotypes and Biologics
Authors: William W. Busse, MD CME / ABIM MOC Released: 1/31/2020 Valid for credit through: 1/31/2021 START ACTIVITY Credits Available Physicians – maximum of 0.25 AMA PRA Category 1 Credit(s)™ ABIM Diplomates – maximum of 0.25 ABIM…
CME / ABIM MOC: Severe Asthma Phenotypes: Patient Identification and Therapy Selection
Authors: Nicola A. Hanania, MD CME / ABIM MOC Released: 1/31/2020 Valid for credit through: 1/31/2021 START ACTIVITY Target Audience and Goal Statement This activity is intended for pulmonologists, allergists & clinical immunologists,…
Sudan red dye: a new agent causing type-2 occupational asthma
Case report – Open Access David Clofent, Miquel de Homdedeu, Mariana Muñoz-Esquerre, María Jesús Cruz & Xavier Muñoz Allergy, Asthma & Clinical Immunology volume 16, Article number: 7 (2020) Abstract Background Sudan red or 1-[(2-methoxyphenyl)azo]-2-naphthol is a low molecular weight…
CME – Chronic Cough With Unknown Cause: Current and Future Management Approaches
This activity is supported by an educational grant from Merck & Co., Inc.0.50 CME 0.50 ABIM MOC 30 MINS $0 FEE Overview Provider Statement This continuing medical education activity is…
Expression of SMARCD1 interacts with age in association with asthma control on inhaled corticosteroid therapy
Research – Open Access Michael J. McGeachie, Joanne E. Sordillo, Amber Dahlin, Alberta L. Wang, Sharon M. Lutz, Kelan G. Tantisira, Ronald Panganiban, Quan Lu, Satria Sajuthi, Cydney Urbanek, Rachel Kelly, Benjamin Saef, Celeste Eng, Sam S. Oh, Alvin T. Kho, Damien C. Croteau-Chonka, Scott T.…
Usability of mepolizumab single-use prefilled autoinjector for patient self-administration
Abstract Objective: To evaluate usability of mepolizumab as a liquid drug product self-administered via a single-use prefilled autoinjector (AI) by patients with severe eosinophilic asthma (SEA), or their caregivers, in-clinic and…